PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.07%
Revenue growth above 1.5x ENPH's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-8.12%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-285.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-437.48%
Negative operating income growth while ENPH is at 26.34%. Joel Greenblatt would press for urgent turnaround measures.
-531.05%
Negative net income growth while ENPH stands at 24.63%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-455.50%
Negative EPS growth while ENPH is at 21.74%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-455.50%
Negative diluted EPS growth while ENPH is at 22.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.89%
Slight or no buybacks while ENPH is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-5.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
152.45%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
35.56%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
148.43%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
148.43%
5Y revenue/share CAGR at 75-90% of ENPH's 174.77%. Bill Ackman would encourage strategies to match competitor’s pace.
148.43%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-93.69%
Negative 10Y OCF/share CAGR while ENPH stands at 176.50%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-93.69%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-93.69%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
80.22%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
80.22%
Below 50% of ENPH's 174.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
80.22%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.25%
AR growth well above ENPH's 17.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
37.61%
Inventory growth well above ENPH's 20.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.15%
Asset growth 1.25-1.5x ENPH's 2.34%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
0.15%
Under 50% of ENPH's 9.32%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-3.92%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
16.71%
We expand SG&A while ENPH cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.